Servier Polska

Servier Polska company information, Employees & Contact Information

Explore related pages

Related company profiles:

Servier to międzynarodowa firma farmaceutyczna z siedzibą we Francji, zarządzana przez fundację non-profit. Unikalny model działania pozwala zawsze stawiać dobro pacjentów ponad zyskiem, dlatego wszystkie przychody Servier reinwestuje w rozwój, z czego ponad 20% w badania. Celem Servier jest stały rozwój wiedzy medycznej i postęp w dostępie pacjentów do skutecznych terapii. Servier obecne jest w 150 krajach i zatrudnia 21 400 osób ca całym świecie. Od 1992 roku firma działa również w Polsce. Od 1997 roku wytwarza tutaj leki. W warszawskim zakładzie produkcyjnym Servier – Anpharm powstaje blisko 100% opakowań leków firmy Servier przeznaczonych dla miliona pacjentów w Polsce. Jednocześnie aż 50% produkcji przeznaczona jest na eksport. Substancje czynne (API) we wszystkich lekach Servier pochodzi z Unii Europejskiej. Od roku 2001 w Warszawie funkcjonuje także Międzynarodowy Ośrodek Badań Klinicznych. Jest jedną z 15 tego typu placówek firmy na świecie. Od 2017 roku odpowiada za prowadzenie badań w Polsce, w Czechach, na Słowacji i Ukrainie, nadzoruje też niektóre projekty w Gruzji. Od początku działalności w Polsce Servier wspiera i podejmuje inicjatywy o charakterze informacyjno-edukacyjnym. Wspiera organizację konferencji naukowych, sympozjów i warsztatów dla lekarzy i farmaceutów. Servier Polska aktywnie wspiera środowisko naukowe grantami badawczymi. Firma Servier organizuje bezpłatne kampanie profilaktyczno-edukacyjne: Servier dla Serca, Servier - Wyłącz Raka oraz Forum Przeciw Depresji. Ich celem jest szerzenie wiedzy na temat profilaktyki przewlekłych chorób cywilizacyjnych, a także zachęcanie pacjentów do diagnostyki. Obecnie Servier Polska zatrudnia ponad 600 pracowników odpowiedzialnych za działalność naukowo-badawczą, produkcję i promocję. W celu zgłoszenia działań niepożądanych zapraszamy na stronę www.servier.pl

Company Details

Employees
106
Address
Burakowska, 14,poland
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
servier.pl
HQ
Wola, Mazowieckie
Looking for a particular Servier Polska employee's phone or email?

Servier Polska Questions

News

Servier tackles environmental challenges, transforming itself for a more sustainable future! - Servier

Servier tackles environmental challenges, transforming itself for a more sustainable future! Servier

1st worldwide in the 2024 PatientView ranking - Cancer Edition - Servier

1st worldwide in the 2024 PatientView ranking - Cancer Edition Servier

Golden Ticket: Servier supports several start-ups - Servier

Golden Ticket: Servier supports several start-ups Servier

Servier is awarded the 2024 Gallup Exceptional Workplace Award - Servier

Servier is awarded the 2024 Gallup Exceptional Workplace Award Servier

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy - Servier

Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy Servier

Servier, buoyed by high-performance R&D, confirms its 2025 trajectory to achieve its 2030 ambition - Servier

Servier, buoyed by high-performance R&D, confirms its 2025 trajectory to achieve its 2030 ambition Servier

Servier and Google Cloud Expand Partnership on using data and AI - Servier

Servier and Google Cloud Expand Partnership on using data and AI Servier

Third-Party Sponsored Studies - Servier

Third-Party Sponsored Studies Servier

Learn more about our development portfolio - Servier

Learn more about our development portfolio Servier

Servier delivers strong results in 2023/2024 and outpaces its trajectory to 2030 - Servier

Servier delivers strong results in 2023/2024 and outpaces its trajectory to 2030 Servier

Boston-Cambridge: a world-renowned innovation hub - Servier

Boston-Cambridge: a world-renowned innovation hub Servier

See our bases throughout the world - Servier

See our bases throughout the world Servier

7 start-ups hosted - Servier

7 start-ups hosted Servier

Our ambition for 2030 - Servier

Our ambition for 2030 Servier

The Group in figures - Servier

The Group in figures Servier

Integrated annual report 2023/2024 - Servier

Integrated annual report 2023/2024 Servier

Spartners by Servier & BioLabs: Biotech start-up welcome to apply! - Servier

Spartners by Servier & BioLabs: Biotech start-up welcome to apply! Servier

Our commitment to neurology - Servier

Our commitment to neurology Servier

Schema describing Servier’s governance structure - Servier

Schema describing Servier’s governance structure Servier

Servier x Owkin: AI-driven precision therapeutics - Servier

Servier x Owkin: AI-driven precision therapeutics Servier

Our commitment to oncology - Servier

Our commitment to oncology Servier

Servier is boosting its digital transformation with Google Cloud! - Servier

Servier is boosting its digital transformation with Google Cloud! Servier

Servier completes its retreat from cell therapy | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Servier completes its retreat from cell therapy | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Servier Presents Transformational Data from Pivotal Phase 3 INDIGO Trial of Vorasidenib in Recurrent or Residual Grade 2 IDH-Mutant Diffuse Glioma - PR Newswire

Servier Presents Transformational Data from Pivotal Phase 3 INDIGO Trial of Vorasidenib in Recurrent or Residual Grade 2 IDH-Mutant Diffuse Glioma PR Newswire

Servier presents its oncology activities at the ESMO Congress - Servier

Servier presents its oncology activities at the ESMO Congress Servier

THRPTX Innovation Summit - our 1st international symposium - Servier

THRPTX Innovation Summit - our 1st international symposium Servier

Servier reveals a new visual identity - Servier

Servier reveals a new visual identity Servier

Servier at ASH meeting to present new data in hematology research - Servier

Servier at ASH meeting to present new data in hematology research Servier

Patient associations’ perception of pharmaceutical companies: Servier is making progress! - Servier

Patient associations’ perception of pharmaceutical companies: Servier is making progress! Servier

Servier shells out $210M upfront to license Ideaya's potential first-in-class PKC inhibitor outside the US - Fierce Biotech

Servier shells out $210M upfront to license Ideaya's potential first-in-class PKC inhibitor outside the US Fierce Biotech

The Research and Development Institute in Paris-Saclay - Servier

The Research and Development Institute in Paris-Saclay Servier

Servier supercharges neuro pipeline with $450M deal for Fragile X syndrome candidate - Fierce Biotech

Servier supercharges neuro pipeline with $450M deal for Fragile X syndrome candidate Fierce Biotech

Fostering a healthy environment - Servier

Fostering a healthy environment Servier

Servier partners with BioLabs to open an incubator in Paris-Saclay for early stage life science start-ups - Servier

Servier partners with BioLabs to open an incubator in Paris-Saclay for early stage life science start-ups Servier

Servier pays $70M to polish Black Diamond's deprioritized solid tumor prospect - Fierce Biotech

Servier pays $70M to polish Black Diamond's deprioritized solid tumor prospect Fierce Biotech

Servier completes acquisition of Agios Pharmaceuticals’ oncology business - Servier

Servier completes acquisition of Agios Pharmaceuticals’ oncology business Servier

The One that Almost Got Away – The CJEU’s Judgments in Servier - Wolters Kluwer

The One that Almost Got Away – The CJEU’s Judgments in Servier Wolters Kluwer

Servier wins the Digital Transformation prize at the BFM Awards! - Servier

Servier wins the Digital Transformation prize at the BFM Awards! Servier

Court reverses Servier verdict on Mediator, ⁠orders payment of €430M - Fierce Pharma

Court reverses Servier verdict on Mediator, ⁠orders payment of €430M Fierce Pharma

All our latest news - Servier

All our latest news Servier

Big Servier Acquisition Pays Off as FDA Approves Drug for Two Types of Rare Brain Cancer - MedCity News

Big Servier Acquisition Pays Off as FDA Approves Drug for Two Types of Rare Brain Cancer MedCity News

Servier's beefing up in oncology through dealmaking and Tibsovo wins—and it's not done yet, U.S. CEO says - Fierce Pharma

Servier's beefing up in oncology through dealmaking and Tibsovo wins—and it's not done yet, U.S. CEO says Fierce Pharma

Black Diamond Therapeutics Trades Well Below Cash After Lucrative Deal With Servier - Seeking Alpha

Black Diamond Therapeutics Trades Well Below Cash After Lucrative Deal With Servier Seeking Alpha

Delta and Aeromexico Challenge U.S. Order to End Joint Venture - PYMNTS.com

Delta and Aeromexico Challenge U.S. Order to End Joint Venture PYMNTS.com

Servier snaps up antibody biotech Symphogen, looks to become 'recognized oncology player' - Fierce Biotech

Servier snaps up antibody biotech Symphogen, looks to become 'recognized oncology player' Fierce Biotech

Servier v. Commission (Case T 691/14): 5 crucial points of the second “pay-for-delay” decision of the EU General Court - Wolters Kluwer

Servier v. Commission (Case T 691/14): 5 crucial points of the second “pay-for-delay” decision of the EU General Court Wolters Kluwer

Jacques Servier, 92, Dies; Accused of Hiding the Risks of Drugs (Published 2014) - The New York Times

Jacques Servier, 92, Dies; Accused of Hiding the Risks of Drugs (Published 2014) The New York Times

Servier, armed with Shire cancer drugs, builds out vision for U.S. future - Fierce Pharma

Servier, armed with Shire cancer drugs, builds out vision for U.S. future Fierce Pharma

Tutorial Videos - Servier Medical Art

Tutorial Videos Servier Medical Art

Servier earns the Best Place to Work certification in Hungary for 2024 - Laotian Times

Servier earns the Best Place to Work certification in Hungary for 2024 Laotian Times

Servier earns the Best Place to Work certification in Hungary for 2024 - Macau Business

Servier earns the Best Place to Work certification in Hungary for 2024 Macau Business

French drugmaker Servier ordered to pay $471m over Mediator scandal - RFI

French drugmaker Servier ordered to pay $471m over Mediator scandal RFI

Servier earns the Best Place to Work certification in Hungary for 2024 - Macau Business

Servier earns the Best Place to Work certification in Hungary for 2024 Macau Business

Servier Canada, in collaboration with Hypertension Canada, launches the GETDOWNBP Hypertension Management mobile App - PR Newswire Canada

Servier Canada, in collaboration with Hypertension Canada, launches the GETDOWNBP Hypertension Management mobile App PR Newswire Canada

Top Servier Polska Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant